Obesity and Weight Gain Are Associated With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- 1 February 2019
- journal article
- research article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 17 (3) , 543-550.e2
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea (NRF-2017R1A2B2008401)
This publication has 34 references indexed in Scilit:
- Systematic review: the diagnosis and staging of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitisAlimentary Pharmacology & Therapeutics, 2010
- Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 yearsGut, 2010
- Randomized Controlled Trial Testing the Effects of Weight Loss on Nonalcoholic SteatohepatitisHepatology, 2009
- The combination of a blood test and Fibroscan improves the non‐invasive diagnosis of liver fibrosisLiver International, 2009
- Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver DiseaseClinical Gastroenterology and Hepatology, 2009
- Orlistat for overweight subjects with nonalcoholic steatohepatitisHepatology, 2009
- Mechanisms linking obesity to insulin resistance and type 2 diabetesNature, 2006
- Long‐term follow‐up of patients with NAFLD and elevated liver enzymes†‡Hepatology, 2006
- Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight lossHepatology, 2004
- Flexible parametric proportional‐hazards and proportional‐odds models for censored survival data, with application to prognostic modelling and estimation of treatment effectsStatistics in Medicine, 2002